During the 2021-2022 flu season, influenza activity in the United States was lower than pre-pandemic levels despite increased reporting and testing, possibly owing to COVID-19 precautions, according to a new report from the US Centers for Disease Control and Prevention (CDC).
For the 2022-2023 season, CDC has updated recommendations for the annual vaccine to include a closer antigenic match to the A(H3N2) subclade that predominated in the 2021-2022 US season, the report notes.
"The 2021-22 influenza season was mild," lead author Angiezel Merced-Morales, MPH, and colleagues write in Morbidity and Mortality Weekly Report. "Influenza activity continued from October 2021 through mid-June 2022, with A(H3N2) viruses predominating throughout the season."
"Since SARS-CoV-2 emerged in the United States in early 2020, influenza activity has been lower than that seen before the pandemic," add the authors, from the CDC's Influenza Division of the National Center for Immunization and Respiratory Diseases.
"The adoption of COVID-19-related mitigation measures might have had an impact on the timing or severity of influenza activity," they write.
The US influenza surveillance system involves collaborations between CDC and state, local, and territorial health departments; clinical and public health laboratories; vital statistics offices; healthcare providers; and hospitals, emergency departments, clinics, and long-term care facilities.
CDC used the cumulative rates of influenza-related hospitalizations reported through FluSurv-NET, as well as a mathematical model to estimate the number of people with symptomatic influenza who had a medical visit, were hospitalized for, or died of influenza.
Using data available from early October 2021 through mid-June 2022, CDC estimated that influenza virus infection resulted in 8-13 million symptomatic illnesses, 3.7-6.1 million medical visits, 82,000-170,000 hospitalizations, and 5000-14,000 deaths.
Clinical laboratories tested more than 2.8 million respiratory specimens for influenza virus. Overall, 4.5% specimens tested positive, including 98.6% for influenza A and 1.4% for influenza B. Each week, between 0.1% and 9.9% of the specimens tested positive for influenza.
Of the nearly 900,000 specimens tested in public health laboratories, 2.8% were positive for influenza virus. Of these, 99.5% were positive for influenza A viruses and 0.5% were positive for influenza B viruses.
Among over 19,000 seasonal influenza A virus specimens that were subtyped, 0.1% were influenza A(H1N1)pdm09 and 99.9% were influenza A(H3N2).
Of the A(H3N2) viruses with age data available, the proportions reported were 10% in people aged 0-4 years, 51% in those aged 5-24 years, 28% in those aged 25-64 years, and 11% those aged 65 years or older. The numbers of reported A(H1N1)pdm09, B/Victoria, and B/Yamagata viruses were too low to analyze by age group.
COVID-19 continued to dominate the deaths from pneumonia, influenza, and/or COVID-19 (PIC). According to the National Center for Health Statistics Mortality Surveillance System, the weekly percentage of PIC deaths remained above the epidemic threshold set at 1.645 standard deviations above the seasonal baseline during the entire 2021-2022 season.
Of the 387,112 PIC deaths, 71.6% of death certificates listed COVID-19 as an underlying or contributing cause of death and 0.6% listed influenza. These numbers indicate that PIC-related deaths were due primarily to COVID-19, not to influenza.
All 31 laboratory-confirmed influenza-related pediatric deaths reported to CDC were linked with an influenza A virus infection, and all 13 influenza A viruses with subtyping information were identified as A(H3N2).
All of the influenza viruses collected and tested for antiviral resistance by CDC were susceptible to zanamivir, and over 99% were susceptible to baloxavir, oseltamivir, and peramivir.
The US Food and Drug Administration's Vaccines and Related Biologic Products Advisory Committee has selected the composition of the 2022-2023 influenza vaccines on the basis of the World Health Organization's recommended Northern Hemisphere 2022-2023 influenza vaccine composition.
The committee updated the recommended A(H3N2) component for the 2022-2023 influenza vaccine to one that belongs to the subclade that predominated in the US during the 2021-2022 season, 3C.2a1b.2a.2. They made no changes to the A(H1N1)pdm09 or the B/Yamagata egg-based, cell-based, or recombinant vaccine recommended components.
Kevin McCarthy, PhD
Commenting on the report to Medscape Medical News, Kevin McCarthy, PhD, assistant professor of microbiology and molecular genetics at the University of Pittsburgh Center for Vaccine Research, said that influenza seasons are notoriously unpredictable.
"Behavioral changes brought about by the SARS-CoV-2 pandemic changed long-standing patterns of influenza circulation," he noted in an email. "This year, the peaks of infection were blunted, the overall severity of the season was diminished, and the season was elongated.
"Our vaccines for the 2022-2023 season have been chosen to match viruses currently circulating during the protracted tail end of the 2021-2022 season," he said. "Perhaps this will help us more closely match the circulating and vaccine viruses.
"As we return to something closer to the pre-pandemic world, will influenza return to its long-held trends?" asked McCarthy, who was not involved in developing the report. "Unfortunately, we will only know after next year's report."
"Regardless of what the future holds," he advises, "receiving the 2022-2023 vaccine is the best way to prepare."
The authors agree.
"Receiving a seasonal influenza vaccine each year remains the best way to protect against seasonal influenza and its potentially severe consequences," they write.
Influenza surveillance reports for the US are published online weekly at https://www.cdc.gov/flu/weekly, and more information about influenza viruses, surveillance, vaccines, antiviral medications, and novel influenza A infections is at https://www.cdc.gov/flu.
The authors and McCarthy report no relevant financial relationships.
Morbidity and Mortality Weekly Report. Published online July 22, 2022. Full text HTML and PDF
For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube
Here is the original post:
CDC Says Recent Flu Season Mild, Maybe Owing to COVID Precautions - Medscape
- 8: Techniques of Molecular Genetics - Biology LibreTexts - January 23rd, 2024
- Molecular Genetics and Metabolism Reports - ScienceDirect - December 18th, 2022
- Molecular Genetics and Metabolism | Journal - ScienceDirect - December 18th, 2022
- Molecular clock - Wikipedia - December 2nd, 2022
- Molecular Structure of Nucleic Acids: A Structure for Deoxyribose ... - December 2nd, 2022
- Molecular Genetics School of Graduate Studies - University of Toronto - October 13th, 2022
- Molecular pathways of major depressive disorder converge on the synapse | Molecular Psychiatry - Nature.com - October 13th, 2022
- Can artificial intelligence help identify best treatments for cancers? LSU researchers say yes - The Advocate - October 13th, 2022
- Results for the fiscal year on June 30, 2022 - Yahoo Finance - October 13th, 2022
- From the journals: MCP - ASBMB Today - October 13th, 2022
- From cave-dweller scientist to Nobel laureate - The Tribune India - October 13th, 2022
- Animal Genetics Market - Know the Revenue and Profit-Sources of the Industry - openPR - October 13th, 2022
- Molecular and Cell Biology and Genetics - Master of Science / PhD ... - September 25th, 2022
- What does the future hold for COVID-19? - UCLA Health Connect - September 25th, 2022
- Farooq Kperogi: Lies and truth about Obi, Atiku, and Tinubu - Peoples Gazette - September 25th, 2022
- Atavistik Bio Announces Formation of Scientific Advisory Board - Business Wire - September 25th, 2022
- Scientific Advances Point to Improved Understanding of Radiation Exposure - Livermore Independent - September 25th, 2022
- 19 million to investigate bold ideas in bioscience research - EurekAlert - September 25th, 2022
- Machel, Iwer among full list of National Awardees - Trinidad Guardian - September 25th, 2022
- Newly Discovered Protein Connected to Alzheimers Disease Risk - Neuroscience News - September 25th, 2022
- The Lab Report: Sharma Lab studies biodiversity of arachnids - The Badger Herald - September 16th, 2022
- Environmental Scientist Jesse Ausubel to Receive 2022 Nierenberg Prize for Science in the Public Interest - Scripps Institution of Oceanography - September 16th, 2022
- Malaria vax promising, to be cheap too - The Hans India - September 16th, 2022
- Dayton Therapeutics Discovers New Therapeutic Uses of Satraplatin for Treatment of Rare Lymphomas - StreetInsider.com - September 16th, 2022
- JNCASRs novel molecule prevents obesity in mice - The Hindu - September 16th, 2022
- Research Fellow in the Department of Medical and Molecular Genetics job with KINGS COLLEGE LONDON | 308234 - Times Higher Education - September 8th, 2022
- Seven Queen's researchers elected to the Royal Society of Canada - Queen's University - September 8th, 2022
- Molecular Biology with an Industrial Placement Year BSc - India Education Diary - September 8th, 2022
- Whole Exome Sequencing Market Projected to Reach CAGR of 19.0% Forecast by 2029, Global Trends, Size, Share, Growth, Future Scope and Key Player... - September 8th, 2022
- Molecular prevalence and genetic diversity of Bartonella spp. in stray cats of zmir, Turkey - Parasites & Vectors - Parasites & Vectors - August 30th, 2022
- How light and temperature work together to affect plant growth - EurekAlert - August 30th, 2022
- Ancient Mummies' Lousy View of the Past - The Scientist - August 30th, 2022
- 'Gray blanket' over Australia: Genetics may have aided European rabbit invasion of continent in 1859, says study - Down To Earth Magazine - August 30th, 2022
- Meet the UNC Pembroke professor leading research on Alzheimers disease - The Robesonian - August 30th, 2022
- Massive Genome Study Informs the Biology of Reading and Language - Neuroscience News - August 30th, 2022
- People in the News at Gencove, IsoPlexis, HTG Molecular, More - GenomeWeb - August 30th, 2022
- Professor (with Head of Department potential), Department of Medical & Molecular Genetics job with KINGS COLLEGE LONDON | 304203 - Times Higher... - August 14th, 2022
- Kathy C. Cordes, a former Baltimore Sun artist who later worked at NASA's Space Telescope Institute, dies Baltimore Sun - Baltimore Sun - August 14th, 2022
- Discovery of the interactions between plants and arbuscular mycorrhizal fungi - EurekAlert - August 14th, 2022
- A new drug could repair stroke damage to memory and movement - Freethink - August 14th, 2022
- Study Using NanoStrings GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics - BioSpace - August 14th, 2022
- New virus detected in China; here's everything you need to know about it - WCCO - August 14th, 2022
- Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine... - August 14th, 2022
- Psychiatry, Fraud, and the Case for a Class-Action Lawsuit - Mad In America - Mad in America - August 14th, 2022
- Scientists Grow Mouse Embryos Without Sperm Or Eggs - EverythingGP - August 14th, 2022
- The Pitfalls of Evolutionary Genomics - SciTechDaily - August 14th, 2022
- How a simple home DNA test unravelled the genetic code that could help prolong my life - The National - August 14th, 2022
- Graduate Research Officer job with UNIVERSITY OF WESTERN AUSTRALIA | 304277 - Times Higher Education - August 14th, 2022
- These Are the Degrees of the Future - Gizmodo - August 14th, 2022
- University of Chicago obituaries - University of Chicago - August 14th, 2022
- Letter: Abortion and social planning - Daily Herald - August 14th, 2022
- Postdoctoral Researcher, Seaweed Molecular Biology, Physiology and Genetics, Ryan Institute, School job with NATIONAL UNIVERSITY OF IRELAND, GALWAY |... - August 5th, 2022
- Researchers crack 30-year-old mystery of odour switching in worms - University of Toronto - August 5th, 2022
- 1st synthetic mouse embryos complete with beating hearts and brains created with no sperm, eggs or womb - Livescience.com - August 5th, 2022
- Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors - Business Wire - August 5th, 2022
- Luke Goldman: Using eDNA to save the Atlantic cod - UMaine News - University of Maine - University of Maine - August 5th, 2022
- Duke Announces Winners of the 2022 DST Spark Seed Grants - Duke Today - July 27th, 2022
- WVXU: UC scientists are deep-freezing molecules. Here's why they're so excited about it - University of Cincinnati - July 27th, 2022
- Better Diagnosis and Treatment: Genetic Clues to Age-Related Macular Degeneration - SciTechDaily - July 27th, 2022
- Regeneron Announces the 2022 Winners of the Regeneron Prize for Creative Innovation - PR Newswire - July 27th, 2022
- Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA - GlobeNewswire - July 27th, 2022
- How is Biotechnology revolutionising food and beverage industry? - The Statesman - July 27th, 2022
- ACP offers guidance on the ethical use of genetic testing and precision medicine - EurekAlert - July 27th, 2022
- Barbour Appointed Dean of The Graduate School and Vice Provost for Graduate Education - Duke Today - July 19th, 2022
- UC scientists are deep-freezing molecules. Here's why they're so excited about it - WVXU - July 19th, 2022
- Research Fellow, Molecular Biology / Recombinant Protein Production and Purification (Biol Sci) job with NATIONAL UNIVERSITY OF SINGAPORE | 301436 -... - July 19th, 2022
- UF researchers discover new way to inhibit virus that causes COVID-19 - University of Florida - July 19th, 2022
- Streamlined Genomic Testing Platforms Are Taking on A Bigger Role in Cancer Care - OncLive - July 19th, 2022
- Bachelor of Science in Biology - National University - July 19th, 2022
- Genes may influence our successes and failures in life, according to Professor Kathryn Paige Harden - ABC News - July 19th, 2022
- Lecturer for Department of Experimental Biology job with MASARYK UNIVERSITY | 301048 - Times Higher Education - July 19th, 2022
- Lecturer in Biology (Education Focused) job with UNIVERSITY OF SYDNEY | 300815 - Times Higher Education - July 19th, 2022
- People's University Is All About Dinosaurs This Summer - Wheeling Intelligencer - July 19th, 2022
- Radiologists hope to use AI to improve readings - University of Miami: News@theU - July 19th, 2022
- Rare Disease Genetic Testing Market 2022 Emerging Trends, Comprehensive Study With Top Companies and Key Players till 2030 - Taiwan News - July 11th, 2022
- Proteases implicated in ulcerative colitis - ASBMB Today - July 11th, 2022
- Cancer has been a scourge for centuries, advances in science have made the disease far less intractable - The Indian Express - July 11th, 2022
- Scientists discover key genes behind insect migrations - EurekAlert - July 11th, 2022
- Neuroimaging Techniques and What a Brain Image Can Tell Us - Technology Networks - July 11th, 2022
- New Research Finally Proves That Coffee Is Safe During Pregnancy - SciTechDaily - July 11th, 2022